Pharmacogenomics Knowledge for Precision Medicine
PharmGKB (pharmgkb.org) scores 73 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, Education brands, Other brands, in the 33rd percentile of 13203 Healthcare brands.
PharmGKB is an online biological database founded in 2001 that curates and disseminates knowledge about how human genetic variation affects response to medications. It aggregates clinically actionable gene-drug associations and genotype-phenotype relationships, serving as a resource for pharmacogenomics research and clinical implementation. The database targets researchers, clinicians, genetic counselors, and students working in pharmacogenomics and precision medicine, positioning itself as a leading curated knowledge base bridging research and clinical practice.
| Brand Name | PharmGKB |
|---|---|
| Domain | pharmgkb.org |
| Industry | Healthcare, Education |
| Founded | 2001 |
| Main Competitors | CPIC, DrugBank (90/100), OMIM (71/100), SNPedia, ClinVar |
Moz Domain Authority 52/100 vs category average 41 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #318,835 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "To curate and provide comprehensive knowledge about how human genetic variation affects response to medications." (No meta description) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: No structured data or Open Graph tags detected. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt mentions GPTBot, ClaudeBot, Google-Extended - all allowed - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Cloudflare.
Social footprint: verified profiles on X (Twitter), LinkedIn, Instagram, GitHub; no detected presence on Facebook, YouTube - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is PharmGKB?", Claude could identify the brand as of October 2026. PharmGKB (Pharmacogenomics Knowledgebase) is a curated resource that collects and disseminates knowledge about how human genetic variation affects drug response, hosted at Stanford University. It provides clinical guideline annotations, drug-gene pathways, and variant annotations Best known for being the leading curated database linking genetic variants to drug response and clinical pharmacogenomic guidelines.
When asked "Best brands similar to PharmGKB?", Claude would recommend PharmGKB as of October 2026. It's a go-to authoritative resource for pharmacogenomics data, so I'd mention it when discussing genomics-driven drug response tools.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
PharmGKB's main competitors in Healthcare: DrugBank (90/100), OMIM (71/100).
Sources: Brand Analyzer scan
PharmGKB has limited AI-search visibility, scoring 28/100 on Brand Analyzer's AI visibility composite (visibility 20, trust 22, recommendation 50). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: PharmGKB official site
PharmGKB was founded in 2001. PharmGKB operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
PharmGKB scores 50/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: PharmGKB official site
PharmGKB is an online biological database, founded in 2001, that curates comprehensive knowledge about how human genetic variation affects response to medications. It functions as a curated knowledge base supporting pharmacogenomics research and the implementation of personalized medicine in clinical settings.
Sources: PharmGKB official site
PharmGKB aggregates, curates, and disseminates knowledge about clinically actionable gene-drug associations and genotype-phenotype relationships. It compiles data from research and clinical sources into a structured database that can be used to understand and apply pharmacogenomic information in research and clinical decision-making.
Sources: PharmGKB official site
PharmGKB can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: PharmGKB official site
PharmGKB offers a curated database of pharmacogenomic knowledge, including information on gene-drug associations and genotype-phenotype relationships. This knowledge base serves as a reference tool for understanding how genetic variation influences drug response, supporting both research and clinical implementation efforts.
Sources: PharmGKB official site
PharmGKB is used by researchers, clinicians, genetic counselors, and students working in pharmacogenomics and precision medicine fields. These users rely on the database to access curated information about gene-drug associations for research, education, and clinical decision-making purposes.
Sources: PharmGKB official site
PharmGKB is known for being a leading curated resource for pharmacogenomic knowledge, specifically for documenting clinically actionable relationships between genetic variants and drug responses. It serves as a trusted reference bridging pharmacogenomics research and clinical practice.
Sources: PharmGKB official site
PharmGKB scores 28/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
PharmGKB has a weak AI-visibility profile at 28/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (50/100) and its weakest is visibility (20/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #318,835 (Tranco) and a Moz Domain Authority of 52/100. The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, thin schema.org structured data and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify PharmGKB from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to PharmGKB: Pharma Test Apparatebau AG (73/100), Pharmaserv (73/100), PHI Aviation LLC (73/100), Photon (73/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.